| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_239171db21e819d16d288959aef51e1d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-341 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341 |
| filingDate |
2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_424bd953f3dc6767d43498ebae83b197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_337658d01fb011cd3773046490244ecf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_390ca21fc881f52ce5d81263f323574a |
| publicationDate |
2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111035635-A |
| titleOfInvention |
Application of Manassantin A or B in the preparation of medicaments for treating Alzheimer's disease |
| abstract |
The invention discloses the application of Manassantin A or Manassantin B and a pharmaceutical combination thereof in the preparation of a medicine for treating Alzheimer's disease, the action mechanism and medicinal effect of Manassantin A or Manassantin B, and has the effect of increasing Aβ clearance; Drugs can be used to treat Alzheimer's disease and diseases related to Aβ. |
| priorityDate |
2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |